Diagnosis and OutcoMes evaluAtIoN of Multicenter Patients With HFpEF Using Multimodality Imaging
Eligible age
All ages
Accepts
All genders
Locations
0 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The incidence of Heart failure with preserved ejection fraction (HFpEF) in Heart failure patients increases rapidly. However, the current clinical awareness is insufficient, and the cardiac structural and functional injury are not well understood. It is difficult to recognize the subclinical changes of the cardiac in the early stage with conventional imaging techniques, and it is common to ignore the existence of the clinical alterations. This study aimed to investigate the cardiac features, early diagnosis and risk factors of HFpEF patients, based on the multi-modality (Magnetic resonance imaging- nuclear medicine imaging- echocardiography) imaging and multicenter study, combined with large data and artificial intelligence. This study will provide deep insights into the HFpEF in multicenter population.
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
You may qualify if…
- ✓ left ventricular ejection fraction (LVEF)≥50%；
- ✓ N-terminal pro-b type natriuretic peptide (NT-proBNP)\>220pg/ml or b type natriuretic peptide (BNP) \>80 pg/ml;
- ✓ symptoms and syndromes of heart failure;
- ✓ At least one criteria of cardiac structure (left ventricular hypertrophy, or left atrial enlargement) and function abnormalities (based on tissue doppler, color doppler).
You may not qualify if…
- ✕ Special types of cardiomyopathy, including hypertrophic cardiomyopathy, restricted cardiomyopathy, etc.
- ✕ Infarction, myocardial fibrosis caused by ischemic cardiomyopathy and acute coronary syndrome ;
- ✕ Severe arrhythmia;
- ✕ Severe primary cardiac valvular disease;
- ✕ Restrictive pericardial disease;
- ✕ Refuse to participate in the study.
Source: ClinicalTrials.gov · NCT04602338 · last updated 2022-04-18